Inflammation and ischemic heart disease: The next therapeutic target? Eduardo M. Vilela; Ricardo Fontes-Carvalho;

Atherothrombotic ischemic disease: The price is too high to ignore Marco Costa;

Optimization of heart failure with reduced ejection fraction prognosis-modifying drugs: A 2021 heart failure expert consensus paper José Silva-Cardoso; Cândida Fonseca; Fátima Franco; João Morais; Jorge Ferreira; Dulce Brito;